All Cosmos Bio-Tech Holding Corp.(TW:4148)
NT$29.40+0.20 (+0.68%)
TW:4148
All Cosmos Bio-Tech Holding Corp. financials statements
NT$29.40
At close:+0.20 (+0.68%)
All Cosmos Bio-Tech Holding Corp. (4148) Ratios
All Cosmos Bio-Tech Holding Corp. Ratios
TW:4148's free cash flow for Q2 2026 was NT$-457.36M. For the 2026 fiscal year, TW:4148's free cash flow was decreased by NT$-14.02M and operating cash flow was NT$-443.33M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.99 | 5.56 | 3.57 | 4.94 | 4.10 |
| Quick Ratio | 3.88 | 4.15 | 2.82 | 3.32 | 2.59 |
| Cash Ratio | 2.00 | 1.95 | 1.85 | 1.97 | 1.32 |
| Solvency Ratio | 0.28 | 0.34 | 0.22 | 0.33 | 0.42 |
| Operating Cash Flow Ratio | 0.41 | 0.11 | 1.21 | 0.06 | -0.12 |
| Short-Term Operating Cash Flow Coverage | 1.01 | 0.23 | 1.89 | 0.11 | -0.22 |
| Net Current Asset Value | NT$ 2.28B | NT$ 2.12B | NT$ 1.96B | NT$ 2.12B | NT$ 1.71B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.07 | 0.15 | 0.23 | 0.10 |
| Debt-to-Equity Ratio | 0.14 | 0.10 | 0.24 | 0.40 | 0.16 |
| Debt-to-Capital Ratio | 0.12 | 0.09 | 0.19 | 0.28 | 0.14 |
| Long-Term Debt-to-Capital Ratio | 0.04 | 0.01 | 0.01 | 0.18 | 0.00 |
| Financial Leverage Ratio | 1.54 | 1.46 | 1.63 | 1.74 | 1.49 |
| Debt Service Coverage Ratio | 1.03 | 0.96 | 0.47 | 1.23 | 0.92 |
| Interest Coverage Ratio | 20.41 | 25.63 | 47.68 | 34.32 | 58.54 |
| Debt to Market Cap | 0.11 | 0.09 | 0.18 | 0.29 | 0.13 |
| Interest Debt Per Share | 4.38 | 4.18 | 8.54 | 15.01 | 4.93 |
| Net Debt to EBITDA | -2.33 | -2.15 | -2.95 | -0.57 | -1.15 |
| Profitability Margins | |||||
| Gross Profit Margin | 28.13% | 27.19% | 20.80% | 30.73% | 27.05% |
| EBIT Margin | 10.06% | 10.53% | 9.26% | 17.63% | 14.84% |
| EBITDA Margin | 12.29% | 12.72% | 10.99% | 18.90% | 16.98% |
| Operating Profit Margin | 10.06% | 6.34% | 6.72% | 17.43% | 12.09% |
| Pretax Profit Margin | 10.08% | 10.28% | 9.11% | 17.12% | 14.64% |
| Net Profit Margin | 5.19% | 5.23% | 4.93% | 9.95% | 9.02% |
| Continuous Operations Profit Margin | 6.99% | 7.10% | 6.51% | 12.26% | 10.69% |
| Net Income Per EBT | 51.45% | 50.87% | 54.09% | 58.08% | 61.61% |
| EBT Per EBIT | 100.26% | 162.16% | 135.67% | 98.21% | 121.07% |
| Return on Assets (ROA) | 3.62% | 3.50% | 3.79% | 8.96% | 6.67% |
| Return on Equity (ROE) | 5.58% | 5.11% | 6.18% | 15.56% | 9.95% |
| Return on Capital Employed (ROCE) | 8.21% | 4.88% | 6.59% | 18.82% | 11.03% |
| Return on Invested Capital (ROIC) | 5.32% | 3.13% | 4.11% | 12.10% | 7.19% |
| Return on Tangible Assets | 3.63% | 3.51% | 3.80% | 8.96% | 6.67% |
| Earnings Yield | 4.42% | 4.39% | 4.64% | 11.24% | 8.10% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.34 | 3.95 | 5.60 | 5.09 | 4.80 |
| Payables Turnover | 11.63 | 20.12 | 17.09 | 30.56 | 16.30 |
| Inventory Turnover | 3.10 | 2.65 | 3.79 | 2.32 | 1.90 |
| Fixed Asset Turnover | 3.26 | 2.62 | 3.52 | 5.49 | 3.58 |
| Asset Turnover | 0.70 | 0.67 | 0.77 | 0.90 | 0.74 |
| Working Capital Turnover Ratio | 1.27 | 1.17 | 1.20 | 1.67 | 1.31 |
| Cash Conversion Cycle | 195.71 | 212.00 | 140.19 | 216.96 | 245.79 |
| Days of Sales Outstanding | 109.31 | 92.50 | 65.17 | 71.76 | 76.09 |
| Days of Inventory Outstanding | 117.79 | 137.64 | 96.37 | 157.15 | 192.11 |
| Days of Payables Outstanding | 31.38 | 18.14 | 21.35 | 11.94 | 22.40 |
| Operating Cycle | 227.09 | 230.14 | 161.54 | 228.91 | 268.19 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.79 | 0.85 | 14.98 | 0.68 | -1.06 |
| Free Cash Flow Per Share | 2.31 | -1.38 | 12.43 | -0.27 | -2.68 |
| Dividend Paid and CapEx Coverage Ratio | 3.37 | 0.26 | 2.97 | 0.28 | -0.40 |
| Capital Expenditure Coverage Ratio | 5.88 | 0.38 | 5.87 | 0.72 | -0.65 |
| Operating Cash Flow Coverage Ratio | 0.66 | 0.21 | 1.77 | 0.05 | -0.22 |
| Operating Cash Flow to Sales Ratio | 0.09 | 0.02 | 0.34 | 0.01 | -0.03 |
| Free Cash Flow Yield | 6.04% | -3.01% | 26.52% | -0.52% | -7.01% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 16.80 | 22.63 | 21.50 | 8.89 | 12.36 |
| Price-to-Sales (P/S) Ratio | 1.17 | 1.19 | 1.06 | 0.88 | 1.11 |
| Price-to-Book (P/B) Ratio | 1.26 | 1.16 | 1.33 | 1.38 | 1.23 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 16.57 | -33.24 | 3.77 | -192.45 | -14.26 |
| Price-to-Operating Cash Flow Ratio | 13.75 | 54.02 | 3.13 | 74.69 | -36.15 |
| Price-to-Earnings Growth (PEG) Ratio | 1.31 | -3.08 | -0.35 | 0.10 | 0.09 |
| Enterprise Value Multiple | 7.23 | 7.21 | 6.71 | 4.11 | 5.41 |
| Enterprise Value | 2.62B | 2.25B | 2.08B | 2.88B | 2.02B |
| EV to EBITDA | 7.23 | 7.21 | 6.71 | 4.11 | 5.41 |
| EV to Sales | 0.89 | 0.92 | 0.74 | 0.78 | 0.92 |
| EV to Free Cash Flow | 12.54 | -25.60 | 2.62 | -169.00 | -11.76 |
| EV to Operating Cash Flow | 10.40 | 41.61 | 2.17 | 65.59 | -29.81 |
| Tangible Book Value Per Share | 37.96 | 48.70 | 43.79 | 44.70 | 37.13 |
| Shareholders’ Equity Per Share | 30.33 | 39.28 | 35.21 | 36.96 | 31.08 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.31 | 0.31 | 0.27 | 0.28 | 0.26 |
| Revenue Per Share | 32.60 | 38.40 | 44.14 | 57.82 | 34.31 |
| Net Income Per Share | 1.69 | 2.01 | 2.18 | 5.75 | 3.09 |
| Tax Burden | 0.51 | 0.51 | 0.54 | 0.58 | 0.62 |
| Interest Burden | 1.00 | 0.98 | 0.98 | 0.97 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.18 | 0.20 | 0.14 | 0.13 | 0.17 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.65 | 0.21 | 6.88 | 0.07 | -0.21 |
Currency in TWD
